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We read with interest the letter of Dr. Batsis regarding our
Surgical Endoscopy article in which we assessed the clin-
ical value of endoscopic ultrasound-guided ﬁne-needle
aspiration (EUS-FNA) for mediastinal lymph nodes in low-
volume EUS centers [1].
We fully agree with the author that EUS-FNA is an
invasive method for staging and sampling mediastinal
lymphadenopathy that may be associated with complica-
tions such as perforations. In addition, FNA is technically
demanding, and it is not easy to determine which lymph
node to puncture because current sonographic criteria for
malignant lymph nodes lack speciﬁcity [2]. However,
EUS-FNA does seem to play a major role in determining
the surgical approach [3], and more important, seems to
avoid futile surgical interventions in both low- and high-
volume EUS centers [1, 4].
Indeed, it would be desirable to avoid such an invasive
method, for instance, by measuring biomarkers in serum
samples. However, we believe that these diagnostic options
currently are not clinically available.
An interesting alternative that may avoid FNA, or at
least decrease the number of ultrasound-guided punctures,
is EUS elastography. This technique, a further develop-
ment of the well-known breast ultrasound fremitus tech-
nique, is based on the fact that a change in tissue resulting
in malignant, ﬁbrotic, inﬂamed or normal tissue may alter
elasticity [5].
Instead of asking the patient to hum for vibration during
color Doppler examination of the breast, for EUS tissue
elasticity imaging, vibrations and compressions are pro-
vided physiologically by vascular pulsation and respiratory
motion. The calculation of tissue elasticity distribution is
performed in real time, and the elasticity results are pre-
sented in different colors projected over the conventional
B-mode image, with malignant tissue appearing in blue,
ﬁbrosis in green, normal tissue in yellow, and fat in red [6].
Unfortunately, only the Pentax EUS-scope (EG 38-UT;
Pentax Europe Gmbh Hamburg, Germany) but not the
Olympus EUS scope (GF-UCT140; Olympus, Hamburg,
Germany) is equipped with this diagnostic tool.
Initial research focusing on breast cancer showed that
tissue elastography correctly classiﬁes benign and malig-
nant tissue [6]. The ﬁrst results for lymph nodes evaluated
with EUS elastography and veriﬁed with ﬁnal cytology
collected by EUS-FNA showed no false-negatives but ﬁve
false-positives, resulting in a sensitivity of 100% and a
speciﬁcity of 50% [5].
The authors concluded that the disappointing speciﬁcity
may improve rapidly with increasing experience and bet-
ter-deﬁned criteria. A larger study recently showed better
diagnostic results with a sensitivity of 100%, a speciﬁcity
of 83%, a negative predictive value of 100%, and a positive
predictive value of 75% [7].
Whether EUS elastography as virtual biopsy will in
some cases replace FNA in the future remains to be
established. However, it may function as a guide for
selecting the most malignant-appearing lymph node for
FNA, consequently reducing the number of false-negative
punctures.
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